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Introduction: Long-term exposure to increased lead (Pb) concentrations is associated with several chronic
diseases. The divalent cation zinc (Zn) is essential for numerous enzymes. In a recent study we found
remarkably elevated concentrations of Pb and Zn in the tidemark (TM), which is the mineralization front
of human articular cartilage.
Objective: Duplication or multiplication of TMs occurs with advancing age or degeneration. We hy-
pothesized that trace elements accumulate in TMs as a function of time. Thus, in cases of double TMs, the
deep (older) TM should contain higher Pb and Zn concentrations than the superﬁcial (younger) TM.
Design: Undecalciﬁed tissue from articular cartilage and subchondral bone of femoral heads and patellae
was examined by synchrotron radiation induced confocal micro X-ray ﬂuorescence analysis and by
quantitative backscattered electron imaging to determine the local distribution of Ca, Zn, and Pb in this
tissue.
Results: The evaluation of X-ray ﬂuorescence intensities in double TMs revealed in average a 2.6-fold
higher Pb level in the deep TM compared to the superﬁcial TM while Zn concentrations were similar. Pb
and Zn contents were signiﬁcantly enhanced in the deep TM (Pb: 35-fold, Zn: ﬁve-fold) and in the su-
perﬁcial TM (Pb: 12-fold, Zn: ﬁve-fold) compared to the bone level.
Conclusion: For the ﬁrst time a differential accumulation of Pb and Zn is documented in regions with
double TMs revealing various timescales for the accumulation of these elements. Increased amounts of
Pb are present in the TMs (up to the 62-fold of the bone level) featuring a potential source of internal Pb
release if the TM region is destroyed.
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The element lead (Pb) is a toxic heavy metal and the exposure to
Pb is associatedwith chronic diseases at thenervous, hematopoietic,
skeletal, renal, and endocrine system1. It is known that Pb accumu-
lates in the skeleton, where approximately 95% of the total body
burden is present2. Osteoblasts and chondrocytes seem to be
important target cells for the toxic effects of Pb3. Clinical studies
indicate that exposure to Pb can lead to osteopenia4,5, osteoporosis6,
impaired bone healing7, and even osteoarthritis8e10. Furthermore, itublished by Elsevier Ltd. All rights reserved.
Table I
List of analyzed samples (n is the number of corresponding measurement ﬁelds)
Sample
(n)
Tissue Sex Age
(years)
Origin Synchrotron
beam line
1 (2) Patella M 46 Autopsy Hasylab, beam L
2 (5) Patella M 54 Autopsy Hasylab, beam L
3 (1) Femoral head F 65 Autopsy Hasylab, beam L
4 (3) Femoral head F 72 Osteoporotic/hip
replacement
Hasylab, beam L
5 (3) Femoral head F 33 Autopsy ANKA, FLUO
6 (1) Femoral head F 76 Osteoporotic/hip
replacement
ANKA, FLUO
7 (1) Femoral head F 85 Osteoporotic/hip
replacement
ANKA, FLUO
8 (1) Femoral head F 79 Osteoporotic/hip
replacement
ANKA, FLUO
9 (1) Femoral head M 62 Osteoarthritic/hip
replacement
Hasylab, beam L
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markers of joint tissue metabolism and may play a role in osteoar-
thritis11. Nelson et al. found a correlation between elevated blood Pb
levels and the incidence of osteoarthritis but question remained if
this is the result of a direct toxic effect of Pb on the joint tissue or if Pb
is released from themineralized tissue12. In contrast to Pb, zinc (Zn)
is an essential trace element, widespread in the reactive center of
various enzymes and crucial for normal growth of the skeleton13.
Even though the role of Zn in bone metabolism is still unknown,
recent studies assumed stimulating effects on bone formation via
facilitation of osteoblastic cell proliferation14. On the other hand a
study on Zn deﬁcient rats indicated no change in bone mineral
density, turnover, architecture, or biomechanics relative to con-
trols15. Until recently, the spatial distribution of Pb and Zn elements
in cartilage and bone were unknown. Using confocal synchrotron
radiation induced micro X-ray ﬂuorescence (SR-mXRF) analysis, we
could characterize the spatial distribution of Pb and Zn in the
osteochondral region of normal adult human joints16. Interestingly,
we found a highly speciﬁc accumulation of Pb and Zn at the inter-
phase betweenmineralized and non-mineralized articular cartilage
(non-mdAC), the so-called tidemark (TM)17.
The TM is of clinical importance since clefts may open in the
cartilage due to injuries and osteoarthritis18,19. The TM represents
the mineralization front in articular cartilage and can be stained
with tetracycline labeling20,21. Moreover, double or even multiple
TMs are observed, when periods of extra-phase mineralization
occur. The number of TMs in the femoral head is reported to in-
crease with age. While below 60 years the average number of TMs
varies between 1 and 1.5 older individuals (above 70) have in
average 1.5e2.5 TMs22. A three-dimensional study of patella sam-
ples revealed a signiﬁcantly increased TM area in osteoarthritis
(7.7 cm2) compared to controls (2.6 cm2)22,23. Whenever a new
mineralization front starts to advance, the older TM is entrapped in
newly mdAC matrix. Therefore, the spatial sequence of TMs also
reﬂects a temporal sequence. However, little is known about
mechanisms and dynamics of the mineralization process of carti-
lage as well as of the accumulation of Pb and Zn, as observed in
single TMs previously16.
In the present work, our hypothesis was that Pb and Zn are
accumulated with time when the mineralization front had stopped
to advance. Hence, the deep TM (deepTM) should have in average
always a higher concentration of Pb and Zn than the superﬁcial TM
(supTM). To prove this assumption we investigated osteochondral
samples from patella and femoral head displaying double TMs us-
ing confocal SR-mXRF in combination with backscattered electron
imaging (BEI).
Material and methods
The study was approved by the ethics committee of the Medical
University of Vienna, Austria (EK 638/2007) and was done in
accordance with the Helsinki Declaration.
Bone samples with double TMs
Osteochondral samples from patellas were obtained from
forensic autopsies (#1, #2). Samples from femoral heads were
retrieved from forensic autopsies (sample #3, #5) or following hip
arthroplasty after osteoporotic femoral neck fractures (sample #4,
#6, #7, #8) (Table I). About 5 mm thick undecalciﬁed blocks of the
Polymethylmethacrylat (PMMA) embedded samples were cut
perpendicular to the articular surface from the central region of the
femoral head (frontal plane) and of patella (sagittal plane). Sample
preparation prior to quantitative backscattered electron imaging
(qBEI) was performed as described elsewhere24e26. The analyzedsamples were part of a sample set of 40 specimens, which were
screened for double TMs after qBEI analysis. The osteochondral
samples containing double TMs were further investigated by SR-
mXRF [n ¼ 6 femoral heads and n ¼ 2 patellae (Table I)]. All patients
had no history of work-related Pb exposure. The average age of the
individuals was 64 years (ranging from 33 to 85). Additionally one
femoral head sample (#9, Table I) with end-stage osteoarthritis was
analyzed, which had completely worn-out cartilage. This sample
was excluded from the main study and is discussed separately.
qBEI
qBEI is a validated technique to visualize and to quantify the
calcium concentration distribution in bone and mineralized carti-
lage with a spatial resolution <1 mm. Therefore, areas with bright
gray levels reﬂect well-mineralized matrix with high Ca content,
whereas areas with dark gray levels indicate low mineral density.
A digital scanning electron microscope (DSM 962, Zeiss, Oberko-
chen, Germany) equipped with a four-quadrant semiconductor BE-
detector was employed to obtain the qBEI data. The microscope was
operated at an acceleration voltage of 20 kV with a working distance
set to 15 mm. The probe current was maintained at 110 pA. More
details on this method can be found elsewhere24e26. Images at 200
magniﬁcation (1 mmspatial resolution)were used for data evaluation.
SR-mXRF e analysis
SR-mXRF is a powerful analytical tool for qualitative and semi-
quantitative analysis of chemical elements, based on the detec-
tion of characteristic X-rays induced by primary high-energy
photons. The sensitivity reaches the femtogram range for me-
dium Z elements. Details on confocal SR-mXRF can be found else-
where16,27e32.
The measurements of this study were performed at confocal SR-
mXRF setups at the micro focus end-station of HASYLAB beam line L
(Hamburg, Germany)33,34 and at the ANKA FLUO beam line
(Karlsruhe, Germany)31,35. Two matched polycarpellary half lenses
from XOS (X-Ray Optical Systems, New York, USA) were installed in
the incident beam and in front of the detector enabling a well-
deﬁned observation volume just below the sample surface.
At HASYLAB beam line L a Ni/C ﬁxed exit double multilayer
monochromator, providing a high photon ﬂux, was used to set the
excitation energy of the primary beam to 18 keV. The size of the
detection volume of 20 mm  14 mm  22 mm (horizontal  vertical
depth) at 9.7 keV (Au-La) was measured by scanning a 4 mm thick
Gold (Au) foil. A 80 mm2 Sirius 80 Si(Li) semiconductor detector
(Grashham, UK) was used to acquire the spectra. Areas of
300 mm  300 mm to 600 mm  600 mm were scanned with a
Fig. 2. Giemsa-stained histological undecalciﬁed PMMA embedded section of sample
#5, exhibiting a double TM region with non-mineralized cartilage (non-mdAC), su-
perﬁcial tidemark (supTM), deep tidemark (deepTM), mineralized cartilage (mdAC),
subchondral bone (BONE).
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(voxel). Elemental maps from ﬂuorescence data were generated by
custom made software and were matched with BE images.
At the ANKA FLOU beam line the excitation energy was set to
17.5 keV by a W/Si multilayer monochromator. The setup was
characterized by means of 0.1 mm thick Au microstructures and
revealed a beam size of 17 mm 10 mm (horizontal vertical) and a
depth resolution at 9.71 keV (Au-La) of 20 mm. The detector was a
50 mm2 silicon drift detector (SDD) (Vortex, SII NanoTechnology,
USA) connected to a digital signal processor (Saturn, XIA, USA). Area
scans on the sample surface were performed in areas of
300 mm  300 mm up to 450 mm  450 mm with a stepwidth of
17 mm horizontal and 10 mm vertical. The acquisition time per
spectrum (pixel) was 60 s, due to the low Pb content.
For each region of interest (ROI), several depth scans were
performed to set themeasurement plane to the region of maximum
Ca-Ka countrate. The acquired spectra were processed using the
“microxrf2” software package (B. Vekemans, XMI, Universiteit
Gent). Peak deconvolution and subtraction of the spectral back-
ground was done with the AXIL36 module implemented in this
package. All obtained intensity data have been normalized to
100 mA ring current and counts per second (cps), and were con-
verted to color coded elemental maps. For measurements, where a
detector sided 15 mm thick Al ﬁlter was used the results were cor-
rected for ﬁlter absorption using BeereLambert’s attenuation law. A
typical ﬂuorescence spectrum of a single measurement point in the
TM is shown in Fig. 1.
Data evaluation
Figure 2 shows a giemsa-stained undecalciﬁed PMMA
embedded section with the characteristic features of a double TM
(sample #5) forming the transition zone between mineralized and
the non-mineralized articular tissue. These characteristic zones
[supTM, deepTM, non-mdAC, mdAC, subchondral bone (BONE)] can
also be easily identiﬁed by qBEI imaging contrast. It was previously
shown that Zn could be considered as a marker for the TM16. So the
Zn-Ka net intensity map (Fig. 3) was used to identify the TMs and to
create 20 mm thin ROIs, marking deepTM and supTM. Ca XRF maps,
Zn XRF maps as well as qBEI images were used to mark regions of
bone packets with homogenous Ca and Zn content and to allocate
the histological regions. The selected ROIs were then applied to the
other elemental maps of the same area scan to calculate relative
elemental concentration in the different histological structures
(Fig. 3). This was done by 2D data evaluation software ImageJ
(v1.44c, National Institutes of Health, USA)37 and Microsoft Excel
2008, using custom made routines. For each individual, average
elemental countrate ratios were calculated for each histological
region, which were used as entity for further evaluation. The non-
parametricWilcoxonmatched-pairs signed rank test was then usedFig. 1. Spectrum of a single measurement point in a TM obtained after 8 s acquisition
time. Bracketed numbers are the maximum counts of the corresponding peaks.to compare the histological regions (sample size: n ¼ 8 for all sta-
tistical analysis). To evaluate the changes in countrate ratios also,
theWilcoxon signed rank test with the hypothetical median value 1
(¼equal elemental distribution) was used. Differences with
P < 0.05 (*) are considered as signiﬁcant. Average values are
expressed by the median, box, and whiskers representing quartiles
and range. The analysis was performed using GraphPad Prism
(v4.0c, GraphPad Software, Inc., USA).Results
Figure 2 shows a giemsa-stained section of a double TM region.
A typical set of images from tissue also containing regions like
BONE, mdAC, deepTM and supTM, and non-mdAC, obtained by
qBEI and SR-mXRF is shown in Fig. 3. An increased Zn concentration
is observed in the supTM and the deepTM. The Pb map also reveals
a higher concentration of Pb in the TMs, but it is distinctly higher in
the deepTM than in the supTM (Fig. 3). A qualitative comparison
revealed no differences between patella samples (sample #1, #2,
male individuals) and femoral heads from female individuals or
between osteoporotic and healthy individuals.Comparison of Pb and Zn concentration between BONE and TMs
Compared to BONE tissue the supTM and deepTM showed
drastically enhanced concentrations of Pb and Zn (Fig. 4). The Pb
content compared to BONE was found to be signiﬁcantly different
in the deepTM and the supTM. While the supTM contained in
median 12 times more Pb than BONE, the deepTM exhibited 35
times higher Pb concentration compared to BONE. Pb concentra-
tions of up to the 62-fold of BONE were observed in the deepTM.
Considering Pb countrate ratio between mdAC and BONE, in all
samples a distinctly lower Pb concentration in BONE was found
compared to mdAC [Fig. 5(b)]. The average Zn content revealed to
be approximately ﬁve-fold higher in both TMs relative to BONE
[Fig. 4(a)]. In contrast to Pb, Zn levels were not signiﬁcantly
different between BONE and mdAC [Fig. 5(b)].
Fig. 3. Quantitative backscattered electron image (qBEI), Pb ﬂuorescence map (Pb) and Zn map (Zn) of a double TM region from sample #2. Note that the color-coding scale is
changed between the elemental maps. In the illustration the histological regions are abbreviated.
Fig. 4. Whisker plots of Zn and Pb levels of the supTM and the deepTM compared to the subchondral bone matrix of the eight analyzed individuals (average age: 46 years, range:
33e85 years, Table I). The ‘þ’ indicates a signiﬁcant difference from a hypothetical equal distribution (dashed line; Wilcoxon-test). (a) Zn concentration in the supTM and the
deepTM normalized to the Zn-BONE level. (b) Pb concentration in the supTM and the deepTM normalized to the Pb-BONE level.
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Fig. 5. Concentration ratios between different histological regions. A ‘þ’ indicates a signiﬁcant difference from a hypothetical equal distribution (dashed line; Wilcoxon-test): (a)
Ratios of Ca, Zn, and Pb between deepTM and supTM of the eight analyzed samples (average individual age: 46 years, range: 33e85 years, Table I). The circles represent a single
sample (#5) with outlying low Pb content. (b) Ratios of Ca, Zn, and Pb between mdAC and BONE (n ¼ 7, in sample #5 no mdAC could be evaluated).
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deepTM
The trace element analysis of regions with double TMs showed
an accumulation of Zn and Pb in the deepTM and the supTM (Fig. 4).
There was only a slight trend (1.2-fold) to an enhanced Zn accu-
mulation in the deepTM compared to the supTM. In contrast, the Pb
concentrationwas 2.9-fold increased in the deepTMwith respect to
the supTM [Fig. 5(a)]. Furthermore, the Pb content in the supTM
varied over a wide rage from the 1.3-fold to the 8.9-fold of that in
the deepTM. Zn concentration ratios were conﬁned to a range be-
tween 0.8 and 1.1 between the TMs. The Ca content was decreased
in the supTM compared to deepTM.A case of outlying low Pb concentration
One individual (sample #5, femoral head, female, 33 years)
showed outlying low Pb concentrations with a relative low Zn
compared to the other samples. Since the Ca concentration of bone
and cartilage, as reﬂected by qBEI, was in the same range like in
the other samples, the Pb/Ca and the Zn/Ca countrate relations can
be used to estimate differences in the total trace element con-
centration between the samples (Fig. 6). This analysis leads to one
to two magnitudes reduced Pb levels in sample #5 in all measured
regions compared to all the other samples. However, despite the
low Pb and Zn levels, the ratios within Pb and Zn between the TMs
ﬁt in the data of the other samples (Fig. 5 e the circle represents
sample #5).Fig. 6. (a) Pb/Ca countrate ratios in regions representative for BONE and for the deepTM.
(b) Zn/Ca countrate ratios in regions representative for BONE and for the deepTM. The
empty circles represent a single sample (#5) with outlying low Pb content.Case of end-stage OA with worn-out cartilage
Figure 7 shows an arthritic sample with totally worn-out carti-
lage (sample #9) and therefore no TM material is left. The Pb
content at the eroded surface of the subchondral bone plate was as
low as the content of the adjacent bone matrix.Discussion
In this study we analyzed the spatial distribution of the trace
elements Pb and Zn in human articular cartilage with double
TMs and BONE using SR-mXRF in combination with qBEI. A highly
increased accumulation of Pb and Zn in the TM regions of
mdAC compared to BONE was found. Interestingly, the Pb con-
centration in the deepTM was always higher than in the supTM,
while the Zn concentrations were similar in both TMs.Different time courses of Pb and Zn accumulation in TMs
The TM represents either a mineralization front advancing into
the non-mdAC or a resting mineralization front. Duplication of the
Fig. 7. (a) Comparison of single TMs (STs) with double TMs (supTM, deepTM) in two of the samples (sample #4: ﬁlled circles, sample #5: empty circles). Each datapoint represents
the average Pb intensity ratio of the TM to BONE of three measurement ﬁelds. (b) Quantitative backscattered electron image (qBEI) of an osteoarthritic bone (sample #9) sample
with a superimposed lead X-ray ﬂuorescence map. The cartilage including the TM is totally worn-out.
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mdAC is occurring (so-called extra-phase mineralization)38. In this
case a newmineralization front moves toward the non-mineralized
cartilage while the former mineralization front remains as an
interface between two phases of mdAC (Figs. 2 and 3). In conse-
quence, the two TMs mark different time points within the carti-
lage. The deepTM represents the older and the supTM the younger
mineralization front. The fact, that the Pb level of the deepTM is
always higher than that of the supTM suggests that Pb accumula-
tion occurs with time after the mineralization front has stopped
moving. Consistently, an supTM as seen in Fig. 3 has relatively low
Pb content compared to deepTM, because the period of Pb accu-
mulation after the mineralization front had stopped was much
shorter. In two of the analyzed samples (sample #4, #5) also
adjacent regions with single TMs were evaluated for the relative Pb
concentration (three regions were averaged per sample) [Fig. 7(a)].
Interestingly there is more Pb accumulated in the single TMs than
in each of the TMs in the double TM regions. In the case of sample
#5 the amount of Pb exceeds the sum of Pb in deepTM and supTM.
This is in linewith our hypothesis, becausewithin a sample, a single
TM is always supposed to have more time for trace element accu-
mulation than an individual TM in a multi-TM region. Moreover,
this conﬁrms the importance of an interface to non-mdAC for the
accumulation of Pb.
This behavior of Pb accumulation is in strong contrast to that of
Zn, which is showing similar Zn content in deepTM and supTM
(Fig. 5). Zn does not seem to accumulate with time in a resting TM,
but Zn is likely an inherent component of the mineralization front
in articular cartilage, which is known to be the metabolically active
zone21. In this context it has to be mentioned that Zn was found in
higher concentration also in the mineralization fronts of osteoid,
which are the regions of new bone formation16. Nonetheless, a
previous study on rats found no link between Zn deﬁciency and
altered bone mineral density, turnover, architecture, or
biomechanics15.
Regarding the mechanism of Pb accumulation it has to be
emphasized that the replacement of Ca by Pb2þ ions in Ca-
hydroxyapatite is a well-known process for high Pb concentra-
tions and is supposed to occur in the same way at low Pb levels39.
Recent X-ray Absorption Near Edge Structure (XANES) measure-
ments evidenced that Pb is present as carbonated Pb-hydroxyap-
atite in the TM as well as in bone tissue40. It can be speculated that
Pb ions in the interstitial tissue ﬂuid of the non-mdAC are taken up
with time selectively by hydroxyapatite minerals. Due to the goodaccessibility of the non-mdAC compared to the mdAC, the Pb
concentration is strongly increased in the TM. In contrast, in regions
behind the TM inside mdAC the Pb uptake is much less, because
these tissue regions were mineralized by an advancing minerali-
zation front and Pb was just incorporated in the mineral during the
mineralization process. This assumption about Pb incorporation is
well supported by studies of the Sr distribution in humans or ani-
mals treated with strontium ranelate41,42. Sr is a bone-seeking
element like Pb and is also incorporated in the hydroxyapatite
crystal. Interestingly, Sr has been taken up predominantly only by
the bone matrix formed during the strontium ranelate treatment.
Moreover, the amount of Sr incorporated in the new bone material
was directly proportional to the level of Sr found in serum42.
It is likely that the interindividual variations in Pb concentration
in BONE and mdAC are reﬂecting the different exposures to envi-
ronmental Pb. Much progress has been made to limit Pb exposure
in industrialized countries, primarily by elimination of leaded
gasoline, and leaded water pipes. Nevertheless, most adults have
already accumulated a substantial body burden of Pb43,44. In
contrast the observed variation in deepTM and supTM is likely
indicating a strong dependency on the duration the resting TMwas
exposed to the interstitial ﬂuid of the non-mdAC tissue. Supposed
that Pb concentrations in the TMs and also in the other histological
regions depend on the Pb concentration of the interstitial ﬂuid, also
a positive correlation between Pb in BONE and in the deepTM is
expected. Figure 6(a) allocates the Pb/Ca countrate ratio of BONE
and the deepTM and illustrates that a higher Pb concentration in
the subchondral bone tissue is linked to increased Pb levels in the
deepTM. Interestingly a similar correlation is obtained for the Zn/Ca
countrate ratio [Fig. 6(b)]. In the younger patient (33 years, sample
#5) the outlying low Pb in BONE, mdAC, deepTM, and supTMmight
reﬂect a scenario of distinctly less environmental Pb exposure.
Remarkably, this specimen also exhibits a relative low Zn content
compared to the other samples (Fig. 6). However, the low Pb and Zn
levels in all histological regions did not cause an outlying behavior
of the ratios of Pb and Zn between deepTM and supTM compared to
the other samples [Fig. 5(a)].
Limitations
The low number of samples examined in this study (n ¼ 9) does
not allow statistical comparisons of trace element accumulation or
TM dynamics between age groups, sex or between osteoporotic and
healthy individuals. Five of sampleswere collected after osteoporotic
A. Roschger et al. / Osteoarthritis and Cartilage 21 (2013) 1707e1715 1713femoral neck fractures. Therefore it cannot be fully excluded that the
presented results include effects linked to osteoporosis.
The spatial resolution of mXRF laterally and in and depth
(w17 mmandw20 mm) generates elemental maps, which cannot be
accurately matched with the qBEI images working with spatial
resolution of w1 mm. Thus, the qBEI images of the diverse tissue
features cannot always directly be assigned to the features seen on
the elemental maps deﬁning the ROI for mXRF elemental evaluation.
The larger information depth of mXRF (w30 mm for Ca-Ka)
compared to qBEI (1e1.5 mm) contributes to blurring of the images.
Further, the calculated relative concentrations of Zn and Pb in TMs,
which are thinner than the X-ray beam diameter, are the result of
averaging the XRF signal over a larger matrix volume than the true
TM feature occupies. Hence, the true relative elemental concen-
tration in the TM is always underestimated by mXRF analysis.
Therefore it gives a lower limit for the real relative elemental
concentration. Furthermore, the limitation in spatial resolution did
not allow determining the exact localization of Zn and Pb accu-
mulation with respect to the Ca content of the TM, which is a
narrow seam with a thickness of about 3 mm. To answer the
question whether trace elements are present right at the border or
inside the mineralized or non-mineralized matrix, linescans at
beamlines with a nanofocus (e.g., P06, PETRA III, DESY, Hamburg,
Germany) would offer such possibilities.
The reported Zn, Pb, and Ca concentrations are not given in
absolute values (weight%), but always in relative photon countrate
ratios of two regions or elements or in absolute XRF countrates
(color coded in Fig. 3). Unfortunately, there are no suitable refer-
ence standards for this novel experimental setup that would have
allowed calculation of absolute Ca, Zn, and Pb values from the X-ray
countrates.
Medical implications
Diseases or situations with increased bone turnover, such as
osteoporosis, pregnancy, hyperthyroidism, and hyperparathyroid-
ism are associated with increased mobilization of Pb from the
skeleton45e47. Age-associated release of bone Pb into the circulation
is a potentially important source of soft-tissue Pb exposure and
toxicity4. A recent work revealed that elevated blood Pb levels are
associated with the prevalence of osteoarthritis. It was shown that
the odds of developing osteoarthritis increases up to 30% depending
on the whole blood lead level. The question remained if this result
represents a direct toxic effect of Pb on the joint tissue, or if osteo-
arthritis causes release of lead stored in the mineralized matrix12.
Our results conﬁrm that the Pb concentration in the TMs can
reach a manifold concentration compared to the bone tissue (up to
the 62-fold) and also indicate an accumulation with time. As a
consequence, in osteoarthritis, where increased resorption of sub-
chondral bone48,49 and additionally a partly or complete loss of the
mdAC and non-mdAC tissue are found, a remarkable amount of Pb
seems to be released into the inﬂammation zone of the joint and
further into circulation during the abrasive process of the articular
cartilage in osteoarthritis. Figure 7(b) shows a sample from a pa-
tient with osteoarthritis with totally worn-out cartilage and with
no TM material left, indicating that the accumulated Pb has been
released into the extracellular ﬂuid during the osteoarthritic pro-
cess. Depending on the amount of stored lead (and therefore on the
history of Pb exposure) and the rate of cartilage abrasion, the
remobilization of Pb might raise the Pb content in the serum to
concentrations of clinical relevance. Thus, further studies are
needed to evaluate the impact of cartilage loss on the Pb bloode
serum levels and therefore to estimate the risk of harming organs,
which are sensitive to heavy metals, like the nervous system and
the hematopoietic compartment.Conclusion
In conclusion our ﬁndings suggest that the trace element
accumulation of Zn and Pb in the TM zones of human adult articular
cartilage is regulated by completely different mechanisms. Zn ap-
pears to be an inherent component of the mineralization front in
articular cartilage and thus it is associated with the metabolic ac-
tivity in this zone. In contrast, Pb seems to be passively but selec-
tively accumulated by the TM with time, after the mineralization
front has stopped to advance. As a result, regions with duplicated
TMs exhibit increased Zn concentrations in both TMs whereas the
accumulation of Pb is much more distinct in the deepTM
(older) than in the supTM (younger). The up to 62-fold increased Pb
concentration found in the TM (compared to the BONE Pb level)
exhibits a potential internal source of Pb release when TM zones are
abrasived during the degenerative process in osteoarthritis.
Author contributions
All authors were involved in drafting or critically reading the
manuscript for important intellectual content, and all authors
approved the ﬁnal version.
Conception and design: A Roschger, JG Hofstaetter, B Pemmer,
N Zoeger, P Wobrauschek, A Berzlanovich, HW Thaler, P Roschger,
K Klaushofer, C Streli.
Data acquisition: A Roschger, B Pemmer, N Zoeger, G Falkenberg,
R Simon, C Streli.
Analysis and interpretation of data: A Roschger, JG Hofstaetter,
B Pemmer, N Zoeger, P Wobrauschek, P Roschger, C Streli.
Provision of study material: A Berzlanovich, HW Thaler.
Obtaining of funding: P Roschger, K Klaushofer, C Streli.
Declaration of funding
This work was supported by the Austrian Science Fund (FWF),
projects P21905-N20 and P15740, the European Commission,
project number I-01038EC and the AUVA (Research funds of the
Austrian workers compensation board) and WGKK (Viennese
sickness insurance funds).
Conﬂict of interests
None of the authors has to disclosure any ﬁnancial or personal
relationship with other people or organizations causing conﬂict of
interests.
Acknowledgments
The authors thank Stephan Smolek for the provision of self-
written software for data processing and Gerda Dinst, Daniela
Gabriel, Sonja Lueger, M.Sc., Phaedra Messmer, and Sabrina Thon
for sample preparation.
References
1. Jarup L. Hazards of heavy metal contamination. Br Med Bull
2003;68:167e82.
2. Wittmers Jr LE, Aufderheide AC, Wallgren J, Rapp Jr G, Alich A.
Lead in bone. IV. Distribution of lead in the human skeleton.
Arch Environ Health 1988;43:381e91.
3. Puzas JE, Sickel MJ, Felter ME. Osteoblasts and chondrocytes
are important target cells for the toxic effects of lead. Neuro-
toxicology 1992;13:783e8.
4. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis:
mobilization of lead from bone in postmenopausal women.
Environ Res 1988;47:79e94.
A. Roschger et al. / Osteoarthritis and Cartilage 21 (2013) 1707e171517145. Escribano A, Revilla M, Hernandez ER, Seco C, Gonzalez-Riola J,
Villa LF, et al. Effect of lead on bone development and bone
mass: a morphometric, densitometric, and histomorphometric
study in growing rats. Calcif Tissue Int 1997;60:200e3.
6. Sun Y, Sun D, Zhou Z, Zhu G, Zhang H, Chang X, et al. Osteo-
porosis in a Chinese population due to occupational exposure
to lead. Am J Ind Med 2008;51:436e42.
7. Carmouche JJ, Puzas JE, Zhang X, Tiyapatanaputi P, Cory-
Slechta DA, Gelein R, et al. Lead exposure inhibits fracture
healing and is associated with increased chondrogenesis, delay
in cartilage mineralization, and a decrease in osteoprogenitor
frequency. Environ Health Perspect 2005;113:749e55.
8. Slavin RE, Swedo J, Cartwright Jr J, Viegas S, Custer EM. Lead
arthritis and lead poisoning following bullet wounds: a clini-
copathologic, ultrastructural, and microanalytic study of two
cases. Hum Pathol 1988;19:223e35.
9. Harding NR, Lipton JF, Vigorita VJ, Bryk E. Experimental lead
arthropathy: an animal model. J Trauma 1999;47:951e5.
10. Bolanos AA, Vigorita VJ, Meyerson RI, D’Ambrosio FG, Bryk E.
Intra-articular histopathologic changes secondary to local lead
intoxication in rabbit knee joints. J Trauma 1995;38:668e71.
11. Nelson AE, Chaudhary S, Kraus VB, Fang F, Chen JC,
Schwartz TA, et al. Whole blood lead levels are associated with
biomarkers of joint tissue metabolism in African American and
white men and women: the Johnston County Osteoarthritis
Project. Environ Res 2011;111:1208e14.
12. Nelson AE, Shi XA, Schwartz TA, Chen JC, Renner JB,
Caldwell KL, et al. Whole blood lead levels are associated with
radiographic and symptomatic knee osteoarthritis: a cross-
sectional analysis in the Johnston County Osteoarthritis Proj-
ect. Arthritis Res Ther 2011;13:R37.
13. Nishi Y. Zinc and growth. J Am Coll Nutr 1996;15:340e4.
14. Ito A, Kawamurab H, Otsukac M, Ikeuchia M, Ohgushia H,
Ishikawad K, et al. Zinc-releasing calcium phosphate for
stimulating bone formation. Mater Sci Eng C 2002;22:21e5.
15. Erben RG, Lausmann K, Roschger P, Schuler C, Skalicky M,
Klaushofer K, et al. Long-term marginal zinc supply is not
detrimental to the skeleton of aged female rats. J Nutr
2009;139:703e9.
16. Zoeger N, Roschger P, Hofstaetter JG, Jokubonis C, Pepponi G,
Falkenberg G, et al. Lead accumulation in tidemark of articular
cartilage. Osteoarthritis Cartilage 2006;14:906e13.
17. Fawns HT, Landells JW. Histochemical studies of rheumatic
conditions. I. Observations on the ﬁne structures of the
matrix of normal bone and cartilage. Ann Rheum Dis 1953;
12:105e13.
18. Kumar P, Oka M, Nakamura T, Yamamuro T, Delecrin J. Me-
chanical strength of osteochondral junction. Nippon Seikei-
geka Gakkai Zasshi 1991;65:1070e7.
19. Landells JW. The reactions of injured human articular cartilage.
J Bone Joint Surg Br 1957;39-B:548e62.
20. Lemperg R. The subchondral bone plate of the femoral head in
adult rabbits. I. Spontaneous remodelling studied by micro-
radiography and tetracycline labelling. Virchows Arch A Pathol
Pathol Anat 1971;352:1e13.
21. Revell PA, Pirie C, Amir G, Rashad S, Walker F. Metabolic ac-
tivity in the calciﬁed zone of cartilage: observations on tetra-
cycline labelled articular cartilage in human osteoarthritic
hips. Rheumatol Int 1990;10:143e7.
22. Lane LB, Bullough PG. Age-related changes in the thickness of
the calciﬁed zone and the number of tidemarks in adult hu-
man articular cartilage. J Bone Joint Surg Br 1980;62:372e5.
23. Bonde HV, Talman ML, Kofoed H. The area of the tidemark in
osteoarthritis e a three-dimensional stereological study in 21
patients. APMIS 2005;113:349e52.24. Roschger P, Fratzl P, Eschberger J, Klaushofer K. Validation of
quantitative backscattered electron imaging for the measure-
ment of mineral density distribution in human bone biopsies.
Bone 1998;23:319e26.
25. Roschger P, Paschalis EP, Fratzl P, Klaushofer K. Bone miner-
alization density distribution in health and disease. Bone
2008;42:456e66.
26. Fratzl-Zelman N, Roschger P, Gourrier A, Weber M, Misof B,
Loveridge N, et al. Combination of nanoindentation and
quantitative backscattered electron imaging revealed altered
bone material properties associated with femoral neck
fragility. Calcif Tissue Int 2009;85:335e43.
27. Zoeger N, Streli C, Wobrauschek P, Jokubonis C, Pepponi G,
Roschger P, et al. Determination of the elemental distribution
in human joint bones by SR micro XRF. X Ray Spectrom
2008;37:3e11.
28. Zoeger N, Wobrauschek P, Streli C, Pepponi G, Roschger P,
Falkenberg G, et al. Distribution of Pb and Zn in slices of human
bone by synchrotron m-XRF. X Ray Spectrom 2005:140e3.
29. Janssens K, Proost K, Falkenberg G. Confocal microscopic X-ray
ﬂuorescence at the HASYLAB microfocus beamline: charac-
teristics and possibilities. Spectrochim Acta B Atom Spectros
2004;59:1637e45.
30. Kanngießer B, Malzer W, Reiche I. A new 3D micro X-ray
ﬂuorescence analysis set-up e ﬁrst archaeometric applica-
tions. Nucl Instrum Methods Phys Res B 2003;211:259e64.
31. Simon R, Kerdpin U, Friedrich F, Faubel W, Weidler PG,
Nüesch R. Depth resolved X-ray ﬂuorescence analysis of cop-
per charged muscovite mica. Adv X Ray Anal 2007;50:64e70.
32. Vincze L, Vekemans B, Brenker FE, Falkenberg G, Rickers K,
Somogyi A, et al. Three-dimensional trace element analysis by
confocal X-ray microﬂuorescence imaging. Anal Chem
2004;76:6786e91.
33. Falkenberg G, Clauss O, Swiderski A, Tschentscher T. Upgrade
of the X-ray ﬂuorescence beamline at HASYLAB/DESY. X Ray
Spectrom 2001;30:170e3.
34. Falkenberg G, Clauss O, Tschentscher T. X-ray Optics for the
MicrofocusBeamlineL.HASYLABAnnualReport 2001.Hamburg.
35. SimonR,ButhG,HagelsteinM.TheX-ray-ﬂuorescence facility at
ANKA, Karlsruhe: minimum detection limits and micro probe
capabilities.Nucl InstrumMethodsPhysResB2003;199:554e8.
36. Van Espen P, Janssens K, Nobels J. AXIL-PC: software for the
analysis of complex X-ray spectra. Chemometr Intell Lab Syst
1986;1:109e14.
37. Schneider CA, RasbandWS, Eliceiri KW. NIH Image to ImageJ: 25
years of image analysis. Nat Methods 2012;9:671e5.
38. Meachim G, Allibone R. Topographical variation in the calciﬁed
zone of upper femoral articular cartilage. J Anat 1984;139(Pt
2):341e52.
39. Bigi A, Ripamonti A, Bruckner S, Gazzano M, Roveri N,
Thomas SA. Structure reﬁnements of lead-substituted calcium
hydroxyapatite by X-ray powder ﬁtting. Acta Crystallogr B
1989;45:247e51.
40. Meirer F, Pemmer B, Pepponi G, Zoeger N, Wobrauschek P,
Sprio S, et al. Assessment of chemical species of lead accu-
mulated in tidemarks of human articular cartilage by X-ray
absorption near-edge structure analysis. J Synchrotron Radiat
2011;18:238e44.
41. Roschger P, Manjubala I, Zoeger N, Meirer F, Simon R, Li C, et al.
Bone material quality in transiliac bone biopsies of post-
menopausal osteoporotic women after 3 years of strontium
ranelate treatment. J Bone Miner Res 2010;25:891e900.
42. Pemmer B, Hofstaetter JG, Meirer F, Smolek S, Wobrauschek P,
Simon R, et al. Increased strontium uptake in trabecular bone of
ovariectomized calcium-deﬁcient rats treated with strontium
A. Roschger et al. / Osteoarthritis and Cartilage 21 (2013) 1707e1715 1715ranelate or strontium chloride. J Synchrotron Radiat 2011;18:
835e41.
43. Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC,
Flegal KM, et al. The decline in blood lead levels in the United
States. The National Health and Nutrition Examination Surveys
(NHANES). JAMA 1994;272:284e91.
44. Vig EK, Hu H. Lead toxicity in older adults. J Am Geriatr Soc
2000;48:1501e6.
45. Osterode W, Reining G, Manner G, Jager J, Vierhapper H.
Increased lead excretion correlates with desoxypyridinoline
crosslinks in hyperthyroid patients. Thyroid 2000;10:161e4.
46. Osterode W, Winker R, Bieglmayer C, Vierhapper H. Effects of
parathyroidectomy on lead mobilization from bone in patients
with primary hyperparathyroidism. Bone 2004;35:942e7.47. Tsaih SW, Korrick S, Schwartz J, Lee ML, Amarasiriwardena C,
Aro A, et al. Inﬂuence of bone resorption on the mobilization of
lead from bone among middle-aged and elderly men: the Nor
mative Aging Study. Environ Health Perspect 2001;109:995e9.
48. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A,
Destefano J, et al. The role of subchondral bone remodeling in
osteoarthritis: reductionof cartilagedegenerationandprevention
ofosteophyte formationbyalendronate in theratanteriorcruciate
ligament transectionmodel. Arthritis Rheum2004;50:1193e206.
49. Hayami T, Pickarski M, Zhuo Y, Wesolowski GA, Rodan GA,
Duong LT. Characterization of articular cartilage and sub-
chondral bone changes in the rat anterior cruciate ligament
transection and meniscectomized models of osteoarthritis.
Bone 2006;38:234e43.
